Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern | Read

  • 1:53
  • Published On: May 06, 2024
Cinema View
Embed
The Supreme Court will hear a petition on a rare side-effect associated with the COVID-19 vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold, in this country, as Covishield. 

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
"Information Is Not New, No Need To Worry": Ex WHO Chief Scientist On Covishield Concern
May 05, 2024 4:56
"All Drugs, Vaccines Come With Some Side-Effects": Top Expert
May 05, 2024 1:07
"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield Concern
May 05, 2024 2:18
Ex WHO Chief Scientist, Top Doctors Answer AstraZeneca Vaccine Concerns
May 05, 2024 26:44
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Covishield Vaccine से हो सकता है Heart Attack! AstraZeneca ने कबूली बात
May 01, 2024 3:36
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination